⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17646863 | 1.00 | — | — | |
| SCHEMBL17646510 | 1.00 | — | — | |
| SCHEMBL28644755 | 0.76 | PGR (0.31) | — | |
| SCHEMBL24112723 | 0.76 | CRBN (0.31) | — | |
| SCHEMBL24112225 | 0.76 | CRBN (0.31) | — | |
| SCHEMBL24112627 | 0.73 | — | — | |
| SCHEMBL24112736 | 0.73 | — | — | |
| SCHEMBL16683268 | 0.73 | — | — | |
| SCHEMBL24187648 | 0.73 | — | — | |
| SCHEMBL24187755 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 124 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11465985-B2 | Processes for making modulators of cystic fibrosis transmembrane conductance regulator | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2022-10-11 | — | — | US | claimed |
| US-11434201-B2 | Processes for preparing pyrrolidine compounds | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2022-09-06 | — | — | US | claimed |
| EP-3661915-B1 | PROCESSES FOR PREPARING PYRROLIDINE COMPOUNDS | VERTEX PHARMA (US) | 2022-03-09 | — | — | EP | claimed |
| US-20210246117-A1 | PROCESSES FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | VERTEX PHARMACEUTICALS (SAN DIEGO) LLC | 2021-08-12 | — | — | US | claimed |
| US-20200369608-A1 | PROCESSES FOR PREPARING PYRROLIDINE COMPOUNDS | VERTEX PHARMACEUTICALS (SAN DIEGO) LLC | 2020-11-26 | — | — | US | claimed |
| EP-3720849-A2 | PROCESSES FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | Vertex Pharmaceuticals Incorporated (US) | 2020-10-14 | — | — | EP | claimed |
| CN-111757874-A | Method for producing modulators of cystic fibrosis transmembrane conductance regulator | 弗特克斯药品有限公司 | 2020-10-09 | — | — | CN | claimed |
| EP-3661915-A1 | PROCESSES FOR PREPARING PYRROLIDINE COMPOUNDS | Vertex Pharmaceuticals Incorporated (US) | 2020-06-10 | — | — | EP | claimed |
| CN-111051280-A | Process for producing pyrrolidine compound | 弗特克斯药品有限公司 | 2020-04-21 | — | — | CN | claimed |
| WO-2019113476-A2 | PROCESSES FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2019-06-13 | — | — | WO | claimed |
| WO-2019028228-A1 | PROCESSES FOR PREPARING PYRROLIDINE COMPOUNDS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2019-02-07 | — | — | WO | claimed |
| US-20260125363-A1 | PROCESSES FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | VERTEX PHARMA (US) | 2026-05-07 | — | — | US | disclosed |
| US-20260108506-A1 | METHODS OF TREATMENT FOR CYSTIC FIBROSIS | VERTEX PHARMACEUTICALS INCORPORATED | 2026-04-23 | — | — | US | disclosed |
| US-20260092047-A1 | MODULATOR OF THE CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR, PHARMACEUTICAL COMPOSITIONS, METHODS OF TREATMENT, AND PROCESS FOR MAKING THE MODULATOR | VERTEX PHARMA (US) | 2026-04-02 | — | — | US | disclosed |
| US-20260034064-A1 | COMPOSITIONS FOR THE TREATMENT OF CFTR-MEDIATED DISEASES | VERTEX PHARMA (US) | 2026-02-05 | — | — | US | disclosed |
| US-4855444-A | α-pyrrolidones and a method for preparation thereof | BASF AKTIENGESELLSCHAFT (DE) | 1989-08-08 | — | — | US | disclosed |
| EP-0260644-A1 | Process for the manufacture of alpha-pyrrolidones and their imines | BASF Aktiengesellschaft (DE) | 1988-03-23 | — | — | EP | disclosed |
| EP-0057444-B1 | DICHLOROAMINO ACID DERIVATIVES USEFUL AS POTENT GERMICIDAL AND FUNGICIDAL AGENTS | MERCK & CO. INC. (US) | 1986-05-07 | — | — | EP | disclosed |
| US-4386103-A | ENVIRONMENT, FOOD TREATMENT, PERSONAL OR VETERINARY HYGIENE | MERCK & CO., INC. (US) | 1983-05-31 | — | — | US | disclosed |
| EP-0057444-A2 | Dichloroamino acid derivatives useful as potent germicidal and fungicidal agents | MERCK & CO. INC. (US) | 1982-08-11 | — | — | EP | disclosed |